WHO ICTRP trial
Differences in maternal temperature and saturation after administration of…
NL-OMON32311 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON32311 |
|---|---|
| Public title | Differences in maternal temperature and saturation after administration of remifentanil PCA or epidural analgesia during labor |
| Scientific title | Differences in maternal temperature and saturation after administration of remifentanil PCA or epidural analgesia during labor - maternal temperature and oxygen saturation during delivery |
| Primary sponsor | Leids Universitair Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | labor pain;10010273;labor pain |
| Interventions | Remifentanil group: 40microgram boluses, lockout time 2 min. Maximum dose limit is 1200 microgram/hour. Epidural group: ropivacaine plus sufentanil. Loading dose 25 mg (12.5 ml ropivacaine 0.2%), followed by continuous infusion of… |
| Registration date | Aug 18, 2008 |
| Target size | 175 |
| Secondary IDs | 2008-002792-28;NL23193.058.08 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: